Contrasting Timing of Virological Relapse After Discontinuation of Tenofovir or Entecavir in Hepatitis B e Antigen–Negative PatientsChristoph Höner zu Siederdissen, Markus Cornberg, Wei Su et al.|The Journal of Infectious Diseases|2018Cited by 58
Nasal route favors the induction of CD4 + T cell responses in the liver of HBV-carrier mice immunized with a recombinant hepatitis B surface- and core-based therapeutic vaccineMaryline Bourgine, Marie‐Louise Michel, Sandrine Crabé et al.|Antiviral Research|2018Cited by 13